Leadership in Personalized Medicine Awarded to George Poste, D.V.M., Ph.D.

We are pleased to announce that George Poste, DVM, PhD, Regents Professor and Del E. Webb Chair in Health Innovation and Chief Scientist, Complex Adaptive Systems Initiative at Arizona State University, will receive the 2025 Award for Leadership in Personalized Medicine at this year’s Personalized Medicine Conference, to be held November 13–14 at the Ritz Carlton, Laguna Niguel, in Dana Point, California. This award recognizes Dr. Poste’s substantial multi-decade contributions to the advancement of personalized medicine and his enduring impact on science, technology, and policy.

A globally respected leader in biomedical innovation, Dr. Poste has made seminal contributions to our understanding of personalized medicine, especially related to tumor heterogeneity and the development of targeted drug delivery systems. As President of R&D at SmithKline Beecham in the 1990s he pioneered the adoption of large-scale genomics in the pharmaceutical industry. He has served on the boards of multiple biotechnology companies, including a foundational role in launching Caris Life Sciences, a company at the forefront of precision oncology combining multiOmics technologies, digital pathology and AI.

In addition to his scientific achievements in drug and diagnostics development, Dr. Poste has served on high-impact policy and advisory bodies including the UK Human Genetics Advisory Committee, creation of the UK Biobank, the U.S. Defense Science Board, the National Academies Forum on Microbial Threats, Bipartisan Commission on Biodefense and the World Economic Forum Board of Medical Governors. He is a member of the UK Royal Society and in recognition of his leadership in the biotechnology and pharmaceutical industries, he was named a Commander of the British Empire (CBE) by Queen Elizabeth II.

On the first day of this year’s Annual Personalized Medicine Conference on November 13, please join in honoring Dr. Poste’s remarkable career and contributions to the field. We look forward to celebrating this achievement and gathering with leaders across science, medicine, and policy in Dana Point.

Visit PersonalizeMedicineConference.org for more information.


Read Next:

Arizona Grants $5M to Barrow for Clinical Trial of Ibogaine in TBI
Barrow Neurological Institute has received a $5 million grant from the Arizona Department of Health Services to study ibogaine treatment in …
Inaugural Chair of Otolaryngology Joins College
Amal Isaiah, MD, PhD, MBA Dr. Amal Isaiah is widely recognized for his work in otolaryngology-head and neck surgery, …
Steve Pressé appointed director of ASU’s Biodesign Center for Single Molecule Biophysics
Steve Pressé, professor at Arizona State University’s School of Molecular Sciences and Department of Physics, has been appointed director …